Suppr超能文献

[基于自身资料(1986 - 1998年)对肾血管性高血压的筛查]

[Screening for renovascular hypertension in own material (1986-1998)].

作者信息

Wańkowicz Z, Smoszna J, Przedlacki J, Stembrowicz Z

机构信息

Kliniki Nefrologii ze Stacja Dializ Centralnego Szpitala Klinicznego WAM.

出版信息

Pol Merkur Lekarski. 1998 Nov;5(29):261-5.

Abstract

In 370 patients (pts) with hypertension(HT) in years 1986-1998 (168F + 202M, mean age 46 yrs) screening value of the following tests was evaluated: standard initial angioscintigraphy DTPA 99mTc(SA) in all pts(1-st screening group), significance of clinical suspicion on renovascular hypertension (RVHT) in the group of 74 pts (II-nd screening group). Captopril tests: renin captopril test(RCT) and isotopic captopril test (ICT) were performed in all 370 pts. Classical renal angiography as a reference test for renal artery stenosis (RAS) was performed in all pts suspected for RVHT on the basis of clinical anamnesis and or positive results of captopril tests. Results were as follows. Initial SA being abnormal in the whole group, appeared to be more significant for RAS only in the case of profound one side renal ischemia (GFR lower than 30% of total GFR). Resistance to three antihypertensive drugs, diastolic blood pressure > 120 mmHg and sudden onset of Ht, found in all 74 pts from the II-nd group, were the most significant clinical symptoms of RVHT, because critical RAS was found in 41, that is 55% of pts from the II-nd group. At least one positive CT was found in 37 from 42 pts with critical RAS in angiography with RTC being more sensitive and ICT more specific for hemodynamically significant RAS. The following screening protocol for RVHT was presented and discussed: precise clinical anamnesis followed by angiography or captopril tests according to the severity of clinical symptoms, aim of the study as well as accessibility and laboratory reproducibility of the captopril tests.

摘要

在1986年至1998年期间对370例高血压(HT)患者(168例女性 + 202例男性,平均年龄46岁)进行研究,评估了以下检查的筛查价值:所有患者(第一筛查组)均进行标准初始血管闪烁造影99mTc - DTPA(SA);在74例患者组(第二筛查组)中评估对肾血管性高血压(RVHT)临床怀疑的意义。对所有370例患者均进行卡托普利试验:肾素卡托普利试验(RCT)和同位素卡托普利试验(ICT)。基于临床病史和/或卡托普利试验阳性结果,对所有怀疑有RVHT的患者进行经典肾血管造影作为肾动脉狭窄(RAS)的参考检查。结果如下。SA初始检查在整个组中异常,仅在严重单侧肾缺血(肾小球滤过率低于总肾小球滤过率的30%)的情况下对RAS更具意义。第二组的所有74例患者中出现的对三种降压药耐药、舒张压>120 mmHg和高血压突然发作,是RVHT最显著的临床症状,因为在41例患者中发现了严重RAS,即第二组患者的55%。在血管造影中42例有严重RAS的患者中,37例至少有一项阳性卡托普利试验结果,其中RCT对血流动力学显著的RAS更敏感,ICT更具特异性。本文提出并讨论了以下RVHT筛查方案:详细的临床病史,然后根据临床症状的严重程度、研究目的以及卡托普利试验的可及性和实验室重复性进行血管造影或卡托普利试验。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验